Characterizing invasiveness in CCCR cells: Role of miR-100, miR-125b and EVs

被引：0
|
作者：
Shameer, Muhammad
Nelson, Hannah M.
Qu, Shimian
Huang, Liyu
Corn, Kevin C.
Chapman, Sydney N.
Luthcke, Nicole L.
Schuster, Sara A.
Stamaris, Tellie D.
Turnbull, Lauren A.
Guy, Lucas L.
Liu, Xiao
Michell, Danielle L.
Semler, Elizabeth M.
Vickers, Kasey C.
Liu, Qi
Franklin, Jeffrey L.
Weaver, Alissa M.
Rafat, Marjan
Coffey, Robert J.
Patton, James G.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2024年 / 23卷 / 11期
关键词：
D O I：
10.1158/1538-8514.RNADRIVERS24-B022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B022
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Transfer of miR-100 and miR-125b increases 3D growth and invasiveness in recipient cancer cells
    Nelson, Hannah M.
    Qu, Shimian
    Huang, Liyu
    Shameer, Muhammad
    Corn, Kevin C.
    Chapman, Sydney N.
    Luthcke, Nicole L.
    Schuster, Sara A.
    Stamaris, Tellie D.
    Turnbull, Lauren A.
    Guy, Lucas L.
    Liu, Xiao
    Michell, Danielle L.
    Semler, Elizabeth M.
    Vickers, Kasey C.
    Liu, Qi
    Franklin, Jeffrey L.
    Weaver, Alissa M.
    Rafat, Marjan
    Coffey, Robert J.
    Patton, James G.
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2024, 5 (03): : 497 - 516
  • [2] miR-100 and miR-125b induce cetuximab resistance in CRC
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 691 - 691
  • [3] miR-100 and miR-125b induce cetuximab resistance in CRC
    Thomas, Hugh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (12) : 691 - 691
  • [4] The expression of miR-125b and miR-100 in OSCC and their contribution to malignancy
    Henson, Brian
    Bhattacharjee, Samsiddhi
    O'Dee, Dawn
    Feingold, Eleanor
    Gollin, Susanne
    CANCER RESEARCH, 2009, 69
  • [5] Decreased Expression of miR-125b and miR-100 in Oral Cancer Cells Contributes to Malignancy
    Henson, Brian J.
    Bhattacharjee, Samsiddhi
    O'Dee, Dawn M.
    Feingold, Eleanor
    Gollin, Susanne M.
    GENES CHROMOSOMES & CANCER, 2009, 48 (07): : 569 - 582
  • [6] TGF-Beta Induces miR-100 and miR-125b Promoting EMT and Stemness in Pancreatic Cancer
    Frampton, A. E.
    Ottaviani, S.
    Stebbing, J.
    Jiao, L. R.
    Castellano, L.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 6 - 6
  • [7] IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Lu, Yuanyuan
    Zhao, Xiaodi
    Liu, Qi
    Li, Cunxi
    Graves-Deal, Ramona
    Cao, Zheng
    Singh, Bhuminder
    Franklin, Jeffrey L.
    Wang, Jing
    Hu, Huaying
    Wei, Tianying
    Yang, Mingli
    Yeatman, Timothy J.
    Lee, Ethan
    Saito-Diaz, Kenyi
    Hinger, Scott
    Patton, James G.
    Chung, Christine H.
    Emmrich, Stephan
    Klusmann, Jan-Henning
    Fan, Daiming
    Coffey, Robert J.
    NATURE MEDICINE, 2017, 23 (11) : 1331 - +
  • [8] lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
    Yuanyuan Lu
    Xiaodi Zhao
    Qi Liu
    Cunxi Li
    Ramona Graves-Deal
    Zheng Cao
    Bhuminder Singh
    Jeffrey L Franklin
    Jing Wang
    Huaying Hu
    Tianying Wei
    Mingli Yang
    Timothy J Yeatman
    Ethan Lee
    Kenyi Saito-Diaz
    Scott Hinger
    James G Patton
    Christine H Chung
    Stephan Emmrich
    Jan-Henning Klusmann
    Daiming Fan
    Robert J Coffey
    Nature Medicine, 2017, 23 : 1331 - 1341
  • [9] TGF-Beta Induces miR-100 and miR-125b Promoting EMT and Stemness in Pancreatic Cancer
    Frampton, A. E.
    Ottaviani, S.
    Stebbing, J.
    Jiao, L. R.
    Heeschen, C.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 21 - 21
  • [10] Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
    Vergani, Elisabetta
    Di Guardo, Lorenza
    Dugo, Matteo
    Rigoletto, Sara
    Tragni, Gabrina
    Ruggeri, Roberta
    Perrone, Federica
    Tamborini, Elena
    Gloghini, Annunziata
    Arienti, Flavio
    Vergani, Barbara
    Deho, Paola
    De Cecco, Loris
    Vallacchi, Viviana
    Frati, Paola
    Shahaj, Eriomina
    Villa, Antonello
    Santinami, Mario
    De Braud, Filippo
    Rivoltini, Licia
    Rodolfo, Monica
    ONCOTARGET, 2016, 7 (04) : 4428 - 4441
12345